the 333-8-9 cells became highly oncogenic in weanling hamsters. No infectious virus was recovered from these cells. Herpes simplex virus antigens were detected in the transformed cells by the indirect immunofluorescence technique. Sera from tumorbearing hamsters contained antibody with highly specific neutralizing activity against HSV-2. These studies indicate the continued involvement of the HSV-2 genome in an oncogenic cell line.
Viruses belonging to herpesvirus groups have been implicated as possible etiological agents in cancer in humans as well as in neoplasms of lower animals (21) . Herpes simplex virus type 2 (HSV-2) was first associated with human cervical carcinoma by epidemiological methods (15, 16, 22) ; however, direct evidence of the role of HSV-2 in cellular transformation has not been obtained. A few tumors have been observed in newborn hamsters after injection of many animals with HSV-2, but virus antigens were not demonstrated in these rare tumors (14) . HSV-2 antigens have been observed in cells isolated from patients in the early stages of cervical carcinoma (2) . In addition to HSV-2, a second herpesvirus has been shown to be associated with human neoplasms. The Epstein-Barr virus has been observed by electron microscope techniques in transformed cells obtained from Burkitt's lymphoma (6, 7). Visual observations of herpesvirus in the transformed cells have been correlated to the presence of circulating antibodies against the virus in the serum of the human host (8) . In addition, recent studies have revealed deoxyribonucleic acid in the Burkitt tumors hybridizable to Epstein-Barr virus deoxyribonucleic acid (25) .
Two other herpesviruses are generally considered to be important in the induction of malignant disease in lower animals. The first is probably the agent which plays an important role in Marek's disease of chickens (4, 17) . In addition, it has recently been reported that Herpesvirus saimiri induces lymphomas when injected into adult primates (10) (11) (12) .
With the possible exceptions mentioned above, direct demonstration of the oncogenic potential by herpesviruses has been extremely difficult. Much of this difficulty results from the characteristic cytopathic effect of HSV which destroys the infected cells soon after in vitro infection. Several investigators have reported that ultraviolet (UV) irradiation of oncogenic viruses does not decrease the oncogenic potential of these viruses as rapidly as it decreases the lytic potential (1, 3, 9) . The cellular cytopathic effect of these UV-irradiated viruses is greatly reduced or removed long before the oncogenic potential is eliminated. Therefore, UV irradiation was chosen as a method with the potential to demonstrate the possible oncogenic activity of HSV. Transformation experiments described in this report were carried out in cell culture as a result of previous observations that this method is more sensitive for the detection of viral transformation than direct injection of animals with the virus (20) . The in vitro and in vivo characterization of hamster cells transformed after infection with UV-irradiated HSV-2 are described in this report.
MATERIALS AND METHODS Cells. Syrian hamster embryo fibroblasts (HEF) cells (inbred LSH strain, Lakeview Hamster Colony, New Field, N.J.) were prepared from 13-day-old embryos by a previously described method (5) . Briefly, the embryos were treated with 0.25% trypsin for 20 min and then centrifuged to remove the trypsin. The cells were suspended in Eagle's medium containing 10% fetal bovine serum, 10% Tryptose phosphate broth, and 0.075% NaHCO3. The newly prepared HEF suspension then was placed into 8-oz (ca. 240 ml) glass prescription bottles at a cell density of 5 X 106 cells per bottle.
Rabbit kidney (RK) cells were prepared from weanling (21-to 28-day-old) rabbit kidneys by a procedure similar to that described for the preparation of HEF. After the trypsinization procedure was complete, the RK cells were suspended in Eagle's medium with 10% fetal bovine serum, 10% Tryptose phosphate broth, and 0.225% NaHCO3. RK cells were grown in 60-mm plastic petri dishes and used for routine HSV assays.
Primary human embryo kidney (HEK) After fixation for 3 min in acetone, HSV-specific antiserum was adsorbed on the cells for 30 min. The cells then were washed three times in Tris buffer and exposed to anti-hamster gamma globulin conjugated to fluorescein isothiocyanate. The cover slips again were washed three times in Tris buffer, air-dried, and mounted on slides. Specific fluorescence was detected by using a Zeiss microscope with a UV light source.
HSV-specific antibody was prepared by injecting weanling Syrian hamsters with HSV-1 or HSV-2 three times at weekly intervals. Viruses used for the first injection were inactivated by UV irradiation for 30 sec. This prevented death of the hamsters after injection. The second and third injection used nonirradiated herpesvirus. At 3 to 5 weeks after the final injection, the hamsters were bled by heart puncture, and, after separation, the serum was stored at -20 C.
Neutralization of HSV. A 0.5-ml amount of an appropriate dilution of serum was mixed with 103 plaque-forming units of HSV-1 or HSV-2. These mixtures were incubated in a 37 C water bath for 40 min. After incubation, 0.1 ml of the virus-serum mixture was placed on an RK cell monolayer in a 60-mm plastic petri dish. Four plates were used per sample. After virus adsorption for 1 hr, the infected cultures were overlaid with Eagle's medium containing 10% fetal bovine serum, 10% Tryptose phosphate broth, 0.23% NaHCO3, and 0.5% methylcellulose. After 4 days, the cells were stained with neutral red, and plaques were counted.
RESULTS
UV inactivation of HSV-1 and HSV-2. Herpes simplex viruses effectively destroy cells infected in vitro. Therefore, a method was necessary which would prevent this rapid cell death, permitting possible HSV-induced transformation to be manifested. UV irradiation was chosen for a variety of reasons, primarily reproducibility of results and rapid reduction of viral cytopathic effect. The UV exposure was calculated to maximize inactivation without destroying transformation potential. A 2-mi amount of the virus was exposed to UV light for various times with constant rotation of the petri dish to insure even exposure. Throughout the times of UV irradiation tested, HSV-2-333 was inactivated at a rate faster than that of its type 1 counterpart (Fig. 1) . This difference of inactivation rates is in accord with results reported by other investigators (24 The transformed cells were stained with hematoxylin and eosin (Fig. 3) to establish the histological patterns of the culture. The 333-8-9 cell culture contained some cells which appeared generally undifferentiated; others appeared to be fibroblastic. A type of giant cell was distributed throughout the cell culture. Transformed 333-8-9 cells were larger, were stained more densely, and had larger nuclei than the control HEF cells. Over 25 control cultures observed in parallel failed to yield transformed foci, and none survived passage 10.
Oncogenicity of transformed cells in Syrian hamsters. To determine the oncogenic potential of the in vitro transformed cell line (333-8-9), 4-week-old LSH hamsters were injected subcutaneously with 10 cells in their 14th passage after viral exposure. These animals were observed for 8 months, and no tumors developed. 2). All cell lines, whether established from the primary in vitro transformation or from the hamster tumors, contained HSV antigens visible as a diffuse fluorescence throughout the cytoplasm of the tumor cell (Fig. 5) . The nuclei of 333-8-9 were relatively free of this type of fluorescence, although some more localized nuclear fluorescence was observed. When these tests were carried out by using normal hamster serum or serum specific for simian virus 40 tumor antigen, no specific immunofluorescence was evident. In addition, when HSV-1-or HSV-2-speci- Antibody specificity of sera from tumor-bearing hamsters. Sera from animals with tumors induced by 333-8-9 cells were collected and examined for the presence of specific HSV antibodies. When indirect immunofluorescence was utilized for this purpose, the sera specifically reacted with RK cells infected by (Table 3) or by HSV-1-Patton. This fluorescence was bright but diffuse throughout the infected cell, the type of fluorescence pattern observed when specific sera known to contain HSV antibodies were used. Serum with antibodies to simian virus 40 tumor antigens did not react with HSV-infected cells. Furthermore, sera from 333-8-9 tumor-bearing hamsters did not react with simian virus 40-infected cells.
Sera from hamsters bearing primary 333-8-9-induced tumors were assayed for the presence of HSV-neutralizing antibodies. Sera from five hamsters with tumors induced by 333-8-9 cells neutralized HSV-2 when the sera were diluted 10-fold (Fig. 6 ). This loss of virus infectivity ranged from 18 to 46% of that observed with un- treated HSV-2. Two sera also were tested at a 1: 5 dilution with a proportionate increase in virus neutralization.
The HSV-2 specificity of this neutralizing activity of primary 333-8-9 sera was tested by replacing the type 2 virus with type 1 virus. Neutralization of HSV-1 (Fig. 7) was significantly less than that observed with HSV-2 (Fig. 6 ). The sera with the highest titers to HSV-2 also had the highest titers to HSV-1.
The hamsters injected with the in vitro transformed 333-8-9 cells were newborn. The age of the hamsters at injection could have resulted in partial immune tolerance in these animals, and therefore antibodies against HSV-1 might not have developed. To test this possibility, weanling hamsters were injected with 101 333-8-9 cells from a primary tumor. Six weeks after injection, the serum from each animal was collected, and its HSV-neutralizing activity was determined. The three sera tested neutralized HSV-2 efficiently (Fig. 8) . Again, the reduction in infectivity of HSV-1 was significantly less (Fig. 9) . For example, the most efficient serum left less than 1% of the HSV-2 infectious, but 25% of the HSV-1 survived. Sera from control hamsters did not neutralize HSV-1 or HSV-2. The specificity of in the cells) that cell surface changes may have occurred in which the antigens of HSV-2 are expressed and that the animal is reacting against these new antigens. Current knowledge concerning changes in the cell surface by HSV would agree with this hypothesis (23) .
It is important to determine the role of the herpesvirus genome in the initiation or 
